Dr Adam Stewart
Dr

Adam Stewart

Email: 

Background

Adam G. Stewart, BBiomedSci, MBBS (Hons), MPHTM, FRACP, FRCPA, PhD

Dr Adam Stewart is is an Australian-trained Infectious Diseases Physician and Clinical Microbiologist. He is currently working on clinical faculty as an Assistant Professor at the University of Texas MD Anderson Cancer Center in Houston, USA. He has previously undertaken post-fellowship subspeciality training in Transplant Infectious Diseases at Massachusetts General Hospital and Harvard University. Dr Stewart is an active physician-scientist with interests in clinical trials, invasive fungal disease, and infections in oncology and transplant patients. Dr Stewart is committed to advancing the management of infections in cancer patients.

Availability

Dr Adam Stewart is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Biomedical Science, Griffith University
  • Bachelor of Medicine and Surgery and Medical Science, Griffith University
  • Masters (Coursework) of Public Health and Tropical Medicine, James Cook University

Research interests

  • Invasive fungal disease

    Clinical and translational research on the causes of early treatment failure and refractory infection in haematological malignancy patients

  • Fungal diagnostics

    Fungal pathogenesis research; host and pathogen biomarker discovery for clinical use for diagnostic and prognostic purposes

  • Clinical trials

    Novel clinical trial design for rare or uncommon pathogens including those causing invasive fungal disease

Search Professor Adam Stewart’s works on UQ eSpace

96 works between 2015 and 2026
All (96) Journal Article (93) Other Outputs (1) Conference Publication (2)

41 - 60 of 96 works

2023

Journal Article

Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature review

Divithotewala, Chandima, Sweeney, Emma L., Burke, Andrew, Graves, Bianca, Stewart, Adam, Whiley, David, Heney, Claire, Hopkins, Peter M. and Chambers, Daniel C. (2023). Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature review. Transplant Infectious Disease, 25 (3) e14058, 1-7. doi: 10.1111/tid.14058

Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature review

2023

Journal Article

Treatment Failure Due to Adaptive Resistance Mechanisms in a Severe and Complicated Bloodstream Infection Due to

Stewart, Adam G., Roberts, Jason A., Forde, Brian M., Bergh, Haakon, Kidd, Timothy J., Wright, Hugh and Harris, Patrick N. A. (2023). Treatment Failure Due to Adaptive Resistance Mechanisms in a Severe and Complicated Bloodstream Infection Due to . Microbial Drug Resistance, 29 (4), 145-149. doi: 10.1089/mdr.2022.0179

Treatment Failure Due to Adaptive Resistance Mechanisms in a Severe and Complicated Bloodstream Infection Due to

2023

Journal Article

First case of mpox diagnosed in Queensland, Australia: clinical and molecular aspects

Stewart, Adam, Schlebusch, Sanmarie, Vlack, Susan, McMahon, Jamie, Sullivan, Mitchell, Pyke, Alyssa and Hajkowicz, Krispin (2023). First case of mpox diagnosed in Queensland, Australia: clinical and molecular aspects. Medical Journal of Australia, 218 (4), 157-159. doi: 10.5694/mja2.51842

First case of mpox diagnosed in Queensland, Australia: clinical and molecular aspects

2022

Journal Article

Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial

Symons, Tanya J., Straiton, Nicola, Gagnon, Rosie, Littleford, Roberta, Campbell, Anita J., Bowen, Asha C., Stewart, Adam G., Tong, Steven Y. C. and Davis, Joshua S. (2022). Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial. Trials, 23 (1) 1055, 1055. doi: 10.1186/s13063-022-07023-z

Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial

2022

Journal Article

Case report: a fatal case of Aspergillus felis infection in an immunocompetent host

Parkes-Smith, Jill, Bauer, Michelle J., Bergh, Haakon, Eidan, Anthony, Forde, Brian M., Hilton, John, Kidd, Timothy J., Schmidt, Campbell, Stewart, Adam G. and Harris, Patrick N. A. (2022). Case report: a fatal case of Aspergillus felis infection in an immunocompetent host. Access Microbiology, 4 (11) acmi000453, 1-4. doi: 10.1099/acmi.0.000453

Case report: a fatal case of Aspergillus felis infection in an immunocompetent host

2022

Journal Article

Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections

Laupland, Kevin B., Harris, Patrick N. A., Stewart, Adam G., Edwards, Felicity and Paterson, David L. (2022). Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections. Diagnostic Microbiology and Infectious Disease, 104 (3) 115772, 1-5. doi: 10.1016/j.diagmicrobio.2022.115772

Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections

2022

Journal Article

Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR

Madden, Danielle E., McCarthy, Kate L., Bell, Scott C., Olagoke, Olusola, Baird, Timothy, Neill, Jane, Ramsay, Kay A., Kidd, Timothy J., Stewart, Adam G., Subedi, Shradha, Choong, Keat, Fraser, Tamieka A., Sarovich, Derek S. and Price, Erin P. (2022). Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR. Journal of Medical Microbiology, 71 (10) 001593, 1-10. doi: 10.1099/jmm.0.001593

Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR

2022

Journal Article

An Australian perspective on antimicrobial stewardship programs and transplantation

Stewart, Adam G., Isler, Burcu and Paterson, David L. (2022). An Australian perspective on antimicrobial stewardship programs and transplantation. Transplant Infectious Disease, 24 (5) e13912, 1-4. doi: 10.1111/tid.13912

An Australian perspective on antimicrobial stewardship programs and transplantation

2022

Journal Article

Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates

Isler, Burcu, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Stewart, Adam, Simos, Peter, Falconer, Caitlin, Bauer, Michelle J., Forde, Brian, Harris, Patrick, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe ... Can, Füsun (2022). Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates. Diagnostic Microbiology and Infectious Disease, 104 (1) 115745, 1-4. doi: 10.1016/j.diagmicrobio.2022.115745

Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates

2022

Journal Article

Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality

Laupland, Kevin B., Paterson, David L., Stewart, Adam G., Edwards, Felicity and Harris, Patrick N. A. (2022). Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality. International Journal of Infectious Diseases, 119, 172-177. doi: 10.1016/j.ijid.2022.03.060

Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality

2022

Journal Article

Reducing the off-target endocrinologic adverse effects of azole antifungals – can it be done?

Balcerek, Matthew I., Stewart, Adam G., Chapman, Paul and Lazarus, Syndia (2022). Reducing the off-target endocrinologic adverse effects of azole antifungals – can it be done?. International Journal of Antimicrobial Agents, 59 (5) 106587, 106587. doi: 10.1016/j.ijantimicag.2022.106587

Reducing the off-target endocrinologic adverse effects of azole antifungals – can it be done?

2022

Journal Article

Painless penile periurethral polymicrobial abscess causing urinary retention

Tariq, Arsalan, Stewart, Adam G., Teloken, Patrick E., Dunglison, Nigel T., Martin, Benjamin F. and Roberts, Matthew J. (2022). Painless penile periurethral polymicrobial abscess causing urinary retention. Urology Case Reports, 42 102037, 1-3. doi: 10.1016/j.eucr.2022.102037

Painless penile periurethral polymicrobial abscess causing urinary retention

2022

Journal Article

Morganella morganii, an emerging cause of bloodstream infections

Laupland, Kevin B., Paterson, David L., Edwards, Felicity, Stewart, Adam G. and Harris, Patrick N. A. (2022). Morganella morganii, an emerging cause of bloodstream infections. Microbiology Spectrum, 10 (3), e0056922. doi: 10.1128/spectrum.00569-22

Morganella morganii, an emerging cause of bloodstream infections

2022

Journal Article

Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia

Simos, Peter A., Holland, David J., Stewart, Adam, Isler, Burcu, Hughes, Ian, Price, Nathan, Henderson, Andrew and Alcorn, Kylie (2022). Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy, 77 (7), 2003-2010. doi: 10.1093/jac/dkac129

Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia

2022

Journal Article

Shewanella spp. bloodstream infections in Queensland, Australia

Laupland, Kevin B, Stewart, Adam G, Edwards, Felicity, Paterson, David L, Coulter, Sonali, Heney, Claire, George, Narelle and Harris, Patrick (2022). Shewanella spp. bloodstream infections in Queensland, Australia. Emerging Infectious Diseases, 28 (4), 701-706. doi: 10.3201/eid2804.212193

Shewanella spp. bloodstream infections in Queensland, Australia

2022

Journal Article

Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID ‐19: a systematic review

Christensen, Jacob, O'Callaghan, Kevin, Sinclair, Holly, Hawke, Kate, Love, Amanda, Hajkowicz, Krispin and Stewart, Adam G. (2022). Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID ‐19: a systematic review. Internal Medicine Journal, 52 (4) imj.15432, 522-529. doi: 10.1111/imj.15432

Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID ‐19: a systematic review

2022

Journal Article

Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritis

Simos, Peter and Stewart, Adam G. (2022). Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritis. Internal Medicine Journal, 52 (2), 332-333. doi: 10.1111/imj.15684

Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritis

2022

Journal Article

Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019

Laupland, Kevin B., Stewart, Adam G., Edwards, Felicity, Harris, Patrick, Heney, Claire, George, Narelle, Coulter, Sonali and Paterson, David L. (2022). Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019. European Journal of Clinical Microbiology and Infectious Diseases, 41 (4), 609-614. doi: 10.1007/s10096-022-04411-w

Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019

2021

Journal Article

Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial

Stewart, Adam G, Henderson, Andrew, Bauer, Michelle J, Paterson, David L and Harris, Patrick N A (2021). Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial. JAC-Antimicrobial Resistance, 4 (1) dlab192, dlab192. doi: 10.1093/jacamr/dlab192

Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial

2021

Journal Article

A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review

Henderson, Andrew, Bursle, Evan, Stewart, Adam, Harris, Patrick N. A., Paterson, David, Chatfield, Mark D., Paul, Mical, Dickstein, Yaakov, Rodriguez-Baño, Jesus, Turnidge, John D. and Kahlmeter, Gunnar (2021). A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review. Clinical Microbiology and Infection, 27 (12), 1746-1753. doi: 10.1016/j.cmi.2021.03.019

A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review

Past funding

  • 2020 - 2022
    Assessing in vitro activity of oral third generation cephalosporin / beta-lactamase inhibitor combinations against extended spectrum beta-lactamase (ESBL) producing uropathogens
    The Royal College of Pathologists of Australasia
    Open grant
  • 2020 - 2021
    USE OF THERAPEUTIC DRUG MONITORING (TDM) TO OPTIMISE ORAL/ENTERAL HYDROXYCHLOROQUINE DOSING IN CRITICALLY ILL PATIENTS WITH COVID-19 (MRFF CRR Respiratory Medicine administered by QUT)
    Queensland University of Technology
    Open grant
  • 2020 - 2025
    COVID-19 Cure Research (Paterson)
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on gut microbiota of hospitalized patients
    Avant Mutual Group Limited
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on the gut microbiome of hospitalized patients
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3
    Merck Sharp & Dohme Australia
    Open grant
  • 2018 - 2021
    A multicentre, Parallel Group Open-label RC Non-Inferiority Trial of piperacillin-tazobactam versus meropenem for definitive treatment of bloodstream infection due to AmpC-producing Enterobacterales
    Junior Doctor Research Fellowships
    Open grant

Availability

Dr Adam Stewart is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Enquiries

Contact Dr Adam Stewart directly for media enquiries about:

  • clinical trial
  • infectious diseases
  • superbugs

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au